← Eichor
Study identifier: NCT07484607 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis

Condition: Cystic Fibrosis (CF) · Cystic Fibrosis Pulmonary Exacerbation  ·  Sponsor: Alexander Horsley

PhaseN/A
Planned participants200
Who can joinAll sexes, 16 Years to no upper limit
Healthy volunteersNo

About this study

The UNIFIED-CF study is an observational study designed to investigate the impacts of treatment given for severe pulmonary exacerbations in people living with cystic fibrosis (pwCF). Exacerbations are episodes when pwCF become more unwell, typically characterised by increased cough, sputum, and breathlessness and treated with a combination of oral and/or intravenous antibiotics. Severe exacerbations require treatment with intravenous antibiotics and impart considerable morbidity on pwCF. In this study, the investigators will recruit people at risk of severe CF exacerbations when they are well and if/when they are subsequently admitted for treatment of an exacerbation, the investigators will track symptoms and lung function during recovery, and collect blood, sputum and stool samples to allow us to explore the biological mechanisms of exacerbations and how they relate to different treatment responses. The study is event driven and will complete recruitment once 125 participants have completed treatment and follow-up for a severe exacerbation event. This study is funded by the Cystic Fibrosis Trust. This study is part of a wider programme of research, led by the PULSE-CF Innovation Hub (and hosted by the University of Manchester). The aim of the Hub is that the data from the UNIFIED-CF study will ultimately support the design of a platform clinical trial to test exacerbation-prevention interventions in CF.

This description comes directly from the study's public registry record.

Talk to the study team

Alexander Horsley, MA MBChB MRCP PhD FERS  ·  01612915869  ·  Alexander.horsley@manchester.ac.uk

Cheuk Ning Sharon Chau  ·  01613060797  ·  cheukningsharon.chau@manchester.ac.uk

Always discuss trial participation with your own doctor first.

Locations (6)

Cardiff and Vale University Health BoardCardiff, United KingdomNot Yet Recruiting
Royal Devon and Exeter Hospital (Wonford)Exeter, United KingdomNot Yet Recruiting
Leeds Adult CF CentreLeeds, United KingdomNot Yet Recruiting
Liverpool Heart & Chest HospitalLiverpool, United KingdomNot Yet Recruiting
Manchester Adult Cystic Fibrosis CentreManchester, United KingdomRecruiting
Newcastle Adult CF CentreNewcastle upon Tyne, United KingdomNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07484607